Literature DB >> 20668384

Acute stroke patients have occult malignancy more often than expected.

Jyunichi Uemura1, Kazumi Kimura, Kensaku Sibazaki, Takeshi Inoue, Yasuyuki Iguchi, Shinji Yamashita.   

Abstract

The aim of the present study was to investigate the frequency of having occult malignancy in patients with acute ischemic stroke and their clinical characteristics. We retrospectively enrolled 1,714 consecutive ischemic stroke patients within 7 days of onset. The patients were divided into two groups: the Non-M group had no malignancy, and the M group had malignancy. We compared the clinical characteristics of the two groups. Of 1,714 ischemic stroke patients, 51 patients (3.0%; M group) were newly diagnosed as having malignancy. The M group was significantly older than the Non-M group (p = 0.009). Hemoglobin (Hb) was less and D-dimer was higher in the M group than in the Non-M group (p < 0.001). The patients with both D-dimer >or=1.3 ng/dl and Hb <12.8 g/dl more frequently had occult malignancy than patients without (p = 0.0088). Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668384     DOI: 10.1159/000316764

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  10 in total

1.  Predictors of unknown cancer in patients with ischemic stroke.

Authors:  Sonia Quintas; Jacobo Rogado; Pedro Gullón; Vilma Pacheco-Barcia; Julio Dotor García-Soto; Gemma Reig-Roselló; Rebeca Mondéjar; Ramón Colomer; Jose Vivancos
Journal:  J Neurooncol       Date:  2018-01-08       Impact factor: 4.130

2.  Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis.

Authors:  Marialaura Simonetto; Stephanie Rutrick; Natalie M LeMoss; Kelsey N Lansdale; Scott T Tagawa; Hooman Kamel; Neal Parikh; Babak B Navi
Journal:  J Stroke Cerebrovasc Dis       Date:  2022-01-13       Impact factor: 2.136

3.  Stroke and Cancer- A Complicated Relationship.

Authors:  Jennifer L Dearborn; Victor C Urrutia; Steven R Zeiler
Journal:  J Neurol Transl Neurosci       Date:  2014

4.  Multiple embolic cerebral infarcts as the first manifestation of metastatic ovarian cancer.

Authors:  Laura M Bond; Darko Skrobo
Journal:  BMJ Case Rep       Date:  2015-10-06

Review 5.  Ischemic stroke in cancer patients: A review of an underappreciated pathology.

Authors:  Babak B Navi; Costantino Iadecola
Journal:  Ann Neurol       Date:  2018-04-30       Impact factor: 10.422

Review 6.  Cancer and Embolic Stroke of Undetermined Source.

Authors:  Babak B Navi; Scott E Kasner; Mitchell S V Elkind; Mary Cushman; Oh Young Bang; Lisa M DeAngelis
Journal:  Stroke       Date:  2021-01-28       Impact factor: 7.914

7.  Intravenous tissue plasminogen activator for an ischemic stroke with occult double primary cancer.

Authors:  Yukihiro Yoneda; Akira Fukuda; Tomohiro Yamazaki; Natsuhi Sasaki; Masahiko Ohta; Yasufumi Kageyama
Journal:  Case Rep Neurol       Date:  2014-10-29

8.  Severe Fatal Systemic Embolism Due to Non-Bacterial Thrombotic Endocarditis as the Initial Manifestation of Gastric Adenocarcinoma: Case Report.

Authors:  Anca Moţăţăianu; Smaranda Maier; Anita Gothard; Zoltán Bajkó; Rodica Bălaşa
Journal:  J Crit Care Med (Targu Mures)       Date:  2018-04-01

Review 9.  Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms.

Authors:  Oh Young Bang; Jong-Won Chung; Mi Ji Lee; Woo-Keun Seo; Gyeong-Moon Kim; Myung-Ju Ahn
Journal:  J Stroke       Date:  2020-01-31       Impact factor: 6.967

10.  Case Report: Brain Metastasis Confined to the Infarcted Area Following Stroke.

Authors:  Dong-Seok Gwak; Yang-Ha Hwang; Yong-Won Kim
Journal:  Front Neurol       Date:  2021-01-29       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.